Patents by Inventor Dale Robinson
Dale Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12262961Abstract: Surgical robot systems, anatomical structure tracker apparatuses, and US transducer apparatuses are disclosed. A surgical robot system includes a robot, a US transducer, and at least one processor. The robot includes a robot base, a robot arm coupled to the robot base, and an end-effector coupled to the robot arm. The end-effector is configured to guide movement of a surgical instrument. The US transducer is coupled to the end-effector and operative to output US imaging data of anatomical structure proximately located to the end-effector. The least one processor is operative to obtain an image volume for the patient and to track pose of the end-effector relative to anatomical structure captured in the image volume based on the US imaging data.Type: GrantFiled: December 26, 2023Date of Patent: April 1, 2025Assignee: Globus Medical, Inc.Inventors: Neil Crawford, Paden Troxell, Dale Earle, Michael Robinson, Keiichi Matsuda, Isaac Dulin
-
Patent number: 12263249Abstract: The invention provides methods for the preparation of particles including one or more agents, e.g., therapeutic or diagnostic agents. The particles can be formed by creating droplets of a first liquid, e.g., including an agent, and removing the first liquid, e.g., through its dispersal in a second liquid and/or evaporation, to solidify the droplets. Advantageously, the process of forming the particles does not significantly alter the structure or activity of the agents and may enhance the stability of the agents. For example, the particles may be stored for long periods of time without significant loss of activity, and in some embodiments, without the need for refrigeration. These particles may be used to generate stabilized pharmaceutical compositions for storage or other logistical purposes, pharmaceutical suspensions, pharmaceutical powder formulations (e.g., inhalable powders, injectable powders), creams or other topical pastes, nutraceuticals, or cosmetics.Type: GrantFiled: June 30, 2021Date of Patent: April 1, 2025Assignee: Elektrofi, Inc.Inventors: Chase Spenser Coffman, Lyndon Fitzgerald Charles, Jr., Paul Brown, Daniel Benjamin Dadon, Lisa Liu, Cory Robinson, Dale Arlington Thomas, III
-
Publication number: 20250017685Abstract: A surgical robot positions an end effector that guides movement of a surgical tool during a surgical procedure on a patient anatomical structure. A tracking system determines a pose of the anatomical structure and a pose of the end effector and/or the surgical tool. A navigation controller determines a target pose for the surgical tool based on a surgical plan and based on the pose of the anatomical structure, and generates steering information based on the target pose for the surgical tool, the pose of the anatomical structure, and the pose of the surgical tool and/or the end effector. The steering information indicates where the surgical tool and/or the end effector need to be moved. An AR headset controller receives the steering information from the navigation controller and displays a graphical representation of the steering information and/or the target pose for the surgical tool on a see-through display screen.Type: ApplicationFiled: September 26, 2024Publication date: January 16, 2025Inventors: Thomas Calloway, Weston Healy, Issac Dulin, Dale Earle, Keiichi Matsuda, Norbert Johnson, Bessam Al Jewad, Christine Russ, Michael Robinson, Keerthighaan Kanagasegar
-
Patent number: 9795607Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.Type: GrantFiled: July 21, 2016Date of Patent: October 24, 2017Assignee: Signal Pharmaceuticals, LLCInventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
-
Publication number: 20160324861Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.Type: ApplicationFiled: July 21, 2016Publication date: November 10, 2016Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
-
Patent number: 9428509Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.Type: GrantFiled: January 15, 2014Date of Patent: August 30, 2016Assignee: Signal Pharmaceuticals, LLCInventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
-
Patent number: 9346812Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.Type: GrantFiled: January 15, 2014Date of Patent: May 24, 2016Assignee: Signal Pharmaceuticals, LLCInventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
-
Publication number: 20140200206Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.Type: ApplicationFiled: January 15, 2014Publication date: July 17, 2014Applicant: Signal Pharmaceutical LLCInventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Mehran Fallah Moghaddam, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning
-
Publication number: 20140200207Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.Type: ApplicationFiled: January 15, 2014Publication date: July 17, 2014Applicant: Signal Pharmaceutical LLCInventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Mehran Fallah Moghaddam, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning
-
Patent number: 8009814Abstract: Method, system, and computer program product for building a voice prompt menu for a collection of portlets by acquiring a list of portlets, building a voice menu comprising voice menu items to activate each of the portlets, acquiring a portlet profile containing customization information, and adapting the voice menu using the customization information in the portlet profile. The web portlet may define custom characteristics for consideration by the voice aggregator, for instance, in the positions for its menu items in the hierarchy of the voice portal menu.Type: GrantFiled: August 10, 2006Date of Patent: August 30, 2011Assignee: International Business Machines CorporationInventors: Dale Robinson Hewitt, William John Izard, Matthew James Ponsford, David Seager Renshaw, Samuel Jonathan Smith
-
Publication number: 20090270418Abstract: Provided herein are Pyrazole Pyrazine Amine Compounds having the following structure: Wherein Q and R1-R3 are as defined herein, compositions comprising an effective amount of a Pyrazole Pyrazine Amine Compound and methods for treating or preventing inflammatory conditions, immunological conditions, cancer, neurodegenerative diseases, age-related diseases, cardiovascular diseases and metabolic conditions, or conditions treatable or preventable by inhibition of an IKK, or an IKK pathway, comprising administering an effective amount of a Pyrazole Pyrazine Amine Compound to a patient in need thereof.Type: ApplicationFiled: January 8, 2009Publication date: October 29, 2009Inventors: Marianne Sloss, Jeffrey McKenna, Won Hyung Yoon, Stephen Norris, Dale Robinson, Jason Parnes, Graziella Shevlin, Paul Erdman, Robert Hilgraf, Ronald Albers, Sayee Hegde, Andrew Wallace, Henry Chan, Loui Madakamutil, Heather Raymon
-
Publication number: 20060030624Abstract: Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth. ?-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase. The compounds can be designed to enhance affinity and/or specificity for a particular protein substrate.Type: ApplicationFiled: October 11, 2005Publication date: February 9, 2006Applicant: Arizona Disease Control Research CommissionInventors: Seth Rose, Steven Ottersberg, Karl Okolotowicz, Dale Robinson, Rosemarie Hartman, Scott Lefler
-
Publication number: 20060030603Abstract: Antibacterial compounds are described herein having either formula (I) or formula (II): wherein R1A, R1B, R1C, R1D, X, Z, Q, R2A, R2B, R2C and R2D are as defined herein. Compositions comprising compounds of formulas (I) and (II) are also provided.Type: ApplicationFiled: August 5, 2004Publication date: February 9, 2006Inventors: Punit Seth, Dale Robinson, Elizabeth Jefferson, Eric Swayze
-
Publication number: 20050032805Abstract: Provided are antibacterial biaryl compounds having micromolar MIC activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain.Type: ApplicationFiled: August 9, 2004Publication date: February 10, 2005Inventors: Elizabeth Jefferson, Eric Swayze, Punit Seth, Dale Robinson
-
Patent number: 6708195Abstract: In a multi-user environment, a method of controlling access to objects is required, such that updates performed by one user are not overwritten by simultaneous updates by another user. There is provided a method of controlling access to objects and containers, each representing a group of objects, in a multi-user environment whereby lock states of the objects and lock states of the containers are stored in a computer system, said method comprising the steps of: accepting a request for access to an object or a container; deciding access based on the lock state for that object or container, the lock state of a container if the request is for an object contained within that container, and the lock state of objects grouped within a container if the request is for a container object; and sending a message to the requester granting or denying access to said object or container object. Updates performed by one user on an object or a container are not overwritten by simultaneous updates by another user.Type: GrantFiled: March 12, 1999Date of Patent: March 16, 2004Assignee: International Business Machines CorporationInventors: Samuel David Borman, Kevin Patrick Corrigan, Dale Robinson Hewitt
-
Patent number: 6400807Abstract: A system for developing and testing a telephony application on a interactive voice system without using associated telephony hardware. The telephony application normally sends and receives hardware signals to and from the system telephony hardware for communication with a telephone. In this invention a telephony emulator intercepts the hardware signals from the voice application and sends back simulated hardware signals to the voice application. A graphical user interface provides the user output in response to the telephony emulator means and accepts and passes on user input to the emulator means.Type: GrantFiled: February 10, 1999Date of Patent: June 4, 2002Assignee: International Business Machines CorporationInventors: Dale Robinson Hewitt, Philip R L Taunton
-
Publication number: 20010044437Abstract: Disclosed are methods of reducing serum uric acid levels, the methods comprising administration of substituted indolealkanoic acids to patients in need of such treatment. Also disclosed are such compounds useful in the treatment of gout and related diseases. Also disclosed are pharmaceutical compositions containing the compounds.Type: ApplicationFiled: January 11, 2001Publication date: November 22, 2001Inventors: Dale Robinson, Marcele Boyd
-
Patent number: 4181991Abstract: An improved mattress foundation particularly suited for use with foam mattresses to provide proper support for the mattress and to duplicate the feel of box springs. The mattress foundation utilizes an upper and lower frame assembly separated by a flexible, resilient material, which may be in the form of blocks, strips or slabs of flexible, resilient material, with the upper frame assembly preferably being somewhat flexible so as to be capable of deforming from its normal planar condition when subjected to more concentrated loads. The material separating the upper and lower frame assemblies are selected to have a resilience which will support the weight of one or two persons while distributed over the mattress foundation without substantial deflection, but which will deflect significantly when subjected to an individual's weight in more concentrated form, such as occurs when an individual sits on the edge of a bed or is getting into or out of the bed.Type: GrantFiled: February 9, 1978Date of Patent: January 8, 1980Assignee: United Foam CorporationInventors: Charles W. Morgan, Dale Robinson, Farouk Farag